The purpose of this study is to compare standard therapy (risk factor control, life style
modification) versus standard therapy plus low-dose rosuvastatin therapy (5mg/day) on
progression of coronary atherosclerosis in statin naive individuals who have mild CAD
(nonobstructive coronary atherosclerotic plaques) and normal LDL (low-density lipoprotein)
cholesterol levels(<130mg/dl).